Jul 18, 2022 4:00 pm EDT Axogen, Inc. Announces Organizational Updates, Preliminary Second Quarter Revenue and Reaffirms Full-Year 2022 Financial Guidance
May 18, 2022 7:00 am EDT Axogen, Inc. to present at the Jefferies Virtual Healthcare Conference and the JMP Securities Life Sciences Conference
May 4, 2022 4:01 pm EDT Axogen, Inc. Announces Positive Topline Results from Phase 3 RECON(SM) Study for Avance® Nerve Graft
Apr 13, 2022 7:00 am EDT Axogen, Inc. to Report First Quarter 2022 Financial Results and Host Conference Call on May 4, 2022
Feb 2, 2022 7:00 am EST Axogen, Inc. to Report Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call on February 22, 2022
